Dementia diagnosis often comes as part of costly crisis

People whose Alzheimer’s disease gets diagnosed as part of a health crisis have much higher costs than those in whom screening shows significant cognitive issues.

11:44 AM

Author | Kara Gavin

brain image lab note
Michigan Medicine

Getting diagnosed with Alzheimer's disease or another kind of dementia is never pleasant – but a new study shows that when and how someone's cognitive issues come to light can also make a big difference in their health care costs.

The study, from a University of Michigan team, uses long-term data from thousands of older adults who either got diagnosed formally, or started to show clear signs of memory and thinking problems on a screening questionnaire they took as part of a long-term study they're in.

Those costs rose sharply – by 150% – from the months just before a formal diagnosis to the months just after it. But for those whose cognitive impairment was identified through screening, there was no jump in costs.

Diving deeper, the researchers show that a health crisis leading to a hospital stay and perhaps a nursing home stay accounted for the sharp spike in costs to the Medicare system at the time of a dementia diagnosis.

In fact, the researchers say, the undiagnosed dementia may have played a role in that health crisis – for instance, by getting in the way of managing conditions or recognizing symptoms.

The study, led by U-M School of Nursing researcher Geoffrey Hoffman, Ph.D., used data from the Health and Retirement Study, which tracks the health of thousands of older adults over time. He and his colleagues received permission to study anonymous data that connects the results of the participants' questionnaires to their Medicare billing records.

In all, they looked at data from 2,779 older adults who received a formal diagnosis of Alzheimer's disease or another dementia, and 2,318 HRS participants whose screening test results strongly suggested they had developed dementia since the last time they took the same screening. All took part in the HRS for multiple years during the time period of 2000 to 2018.

The analysis shows that overall Medicare costs jumped from about $5,400 in the three months before a dementia diagnosis to nearly $13,800 in the three-month period that included the diagnosis, with the dementia diagnosis occurring at the same time patients were treated for strokes, sepsis, heart failure, urinary tract infections and more. For those whose impairment was noted on a screening test but not formally diagnosed, costs stayed steady at about $2,900 for the three-month periods before and after they were screened.

"This fits a broader pattern, in terms of spending after incident diagnoses of chronic disease or injury – there are often sharp, immediate upticks in spending for treatment. But uniquely, spikes in spending after a dementia diagnosis may reflect costs associated with a health care crisis in which the dementia is a contributing factor, rather than the primary factor," said Hoffman, an assistant professor and member of the U-M Institute for Healthcare Policy and Innovation. "More attention to and support for patients with cognitive decline earlier on may have health benefits and spending implications."

The United States Preventive Services Task Force does not formally recommend screening older adults for dementia because the evidence about the impact of screening on patient outcomes is inconclusive. But many tests are available for people to take themselves or for health providers to give.

In addition to Hoffman, the study's authors are Donovan T. Maust, M.D., M.S., Melissa Harris, R.N., Ph.D., Jinkyung Ha, Ph.D., and Matthew A. Davis, Ph.D.

Funding/disclosures: Center to Accelerate Population Research in Alzheimer's (AG066582).

Paper cited: "Medicare spending associated with a dementia diagnosis among older adults," Journal of the American Geriatrics Society. DOI: 10.1111/jgs.17835

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts.


More Articles About:

Lab Notes Alzheimer's Disease Health Care Delivery, Policy and Economics Health Screenings Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Young boy in purple t-shirt sits smiling in the grass on a sunny day.
Health Lab

From 20 seizures a day to more time for play: How personalized epilepsy care helped young patient

Advanced genetic testing and a detailed diagnosis revealed infant’s rare epilepsy, leading to a non-conventional therapy.
Medicaid magnifying glass
Health Lab

What’s changing in Medicaid and what can you do?

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation
David Diebold smiles as he rings the bell at the end of the HURT100.
Philanthropy News

Going the extra 100 miles

U-M Medical School student runs the HURT100 ultramarathon to raise funds for the Michigan Alzheimer's Disease Center and the Alzheimer's Association.
Elderly man stands outside in a snowy neighborhood. He is holding a white mug of coffee in his right hand and has his left hand in a coat pocket. He is staring ahead, presumably taking in the snowy scene around him.
Health Lab

Small daily activities may help ease dementia caregivers’ stress

University of Michigan research suggests engaging in positive activities can improve the mood and physical wellbeing of Alzheimer’s disease or related dementia caregivers.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
A hand holding a prescription bottle with a dollar bill in it
Health Lab

Top 7 tips for choosing Medicare prescription drug coverage for 2027

Prescription drug coverage through Medicare Advantage and Part D plans in traditional Medicare has changed for 2027, and older adults may not know about programs that could help with costs.